Life Sciences IP Focus 2012

  • Editorial

  • Interview: Robert Armitage, Eli Lilly

    The American Invents Act could have a big effect on the life sciences industry. Kevin Matha spoke with Robert A Armitage, senior vice president and general counsel at Eli Lilly, about the new legislative package

  • Interview: Looking back on decades of industry change

    Tom Ciotti and Kate Murashige of Morrison & Foerster have been involved with the life sciences industry for almost 50 years. Phillip Bausk spoke with them about the changes they have seen in that time

  • Europe: Patenting plant breeding

    Edward J Farrington of Inspicos considers the role of human intervention when acertaining the limits of patentability in plant breeding

  • Europe: Selection inventions

    Louise Tottie and Anette Romare of Valea outline important aspects of selection inventions relating to lists and ranges, to consider when drafting patent applications

  • Mexico: New practice on medical-use claims

    Agustín Azcatl, Daniel Sánchez and Pedro Herrera of Olivares & Cia explain the impact of rule changes on first medical-use claims

  • US: The America Invents Act

    Ha Kung Wong and John Kirkland of Fitzpatrick Cella Harper & Scinto use three scenarios to examine the impact of the Act and the future of paragraph IV litigation


profile

Managing IP

ManagingIP

ManagingIP profile

Switzerland: Venus rejected by Federal Administrative Court #trademark (sponsored) http://t.co/FsK30pcpgS

Jul 31 2014 10:30 ·  reply ·  retweet ·  favourite
ManagingIP profile

Interesting graphic. MT: EU consultation on #Copyright Reveals Chasm Between Public And Publishers - https://t.co/EwLDLOksCh via @glynmoody

Jul 31 2014 09:39 ·  reply ·  retweet ·  favourite
ManagingIP profile

Greece: Court rules on abuse of process in trademark matters (sponsored) http://t.co/YwwMfCjVk6

Jul 31 2014 07:20 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


July/August 2014

IP’s most influential people 2014

The 50 people in social media, advocacy and debate influencing IP policy



Most read articles

Supplements